vaccine

Pfizer stock fell on pessimistic guidance as the company prepares to drop a Covid vaccine

Pfizer stock fell on pessimistic guidance as the company prepares to drop a Covid vaccine

font size Pfizer said it expects Covid-19 vaccine sales to fall to $13.5 billion in 2023. Mario Tama/Getty Images Pfizer Tuesday set guidance for fiscal year 2023 well below Wall Street consensus numbers, dampening investor expectations ahead of what is expected to be a sharp drop in sales of Covid-19 products. Shares fell 3% in …

Pfizer stock fell on pessimistic guidance as the company prepares to drop a Covid vaccine Read More »

The change to the formulation of the Covid vaccine signals the beginning of the FDA's pivot in immunization strategy

The change to the formulation of the Covid vaccine signals the beginning of the FDA’s pivot in immunization strategy

Recent evidence indicates that current bivalents provide protection against severe disease and death from the XBB.1 variant that is currently prevalent in the United States. “We’ve turned the corner from a pandemic phase to an endemic phase,” said Ofer Levy, a staff physician at Boston Children’s Hospital, a professor at Harvard Medical School and a …

The change to the formulation of the Covid vaccine signals the beginning of the FDA’s pivot in immunization strategy Read More »

FDA advisors recommend replacing the original Covid vaccine with bivalent Omicron shots for all doses

FDA advisors recommend replacing the original Covid vaccine with bivalent Omicron shots for all doses

The Food and Drug Administration’s independent advisory panel on Thursday recommended replacing Pfizer and Moderna’s original Covid vaccine used in the United States in everyone’s first immunization with new bivalent Omicron shots. If the FDA accepts the advisors’ recommendation, the US will likely phase out corporate vaccines developed in 2020 against the original Covid-19 strain …

FDA advisors recommend replacing the original Covid vaccine with bivalent Omicron shots for all doses Read More »

CDC identifies potential safety issue with Pfizer's updated Covid-19 vaccine but says people still need to be boosted |  CNN

CDC identifies potential safety issue with Pfizer’s updated Covid-19 vaccine but says people still need to be boosted | CNN

CNN – The US Centers for Disease Control and Prevention said on Friday that there is a potential safety issue with a bivalent Covid-19 vaccine being made by Pfizer and BioNTech, but that it is unlikely to present a real risk. The agency said it continues to recommend that people stay up to date on …

CDC identifies potential safety issue with Pfizer’s updated Covid-19 vaccine but says people still need to be boosted | CNN Read More »